Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.2200
+0.3400
+(38.64%)
At close: February 26 at 9:55:01 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
101,710
143,425
139,247
20,486
Total Liabilities Net Minority Interest
50,532
57,385
20,880
12,865
Total Equity Gross Minority Interest
51,178
86,040
118,367
7,621
Total Capitalization
51,178
86,040
122,651
11,225
Common Stock Equity
51,178
86,040
118,367
7,621
Capital Lease Obligations
1,031
810
581
478
Net Tangible Assets
51,178
86,040
118,367
7,621
Working Capital
83,956
118,579
125,257
10,887
Invested Capital
56,460
90,680
122,651
11,225
Tangible Book Value
51,178
86,040
118,367
7,621
Total Debt
6,313
5,450
4,865
4,082
Share Issued
26,289.0870
26,289.0870
25,775.5380
25,352.2570
Ordinary Shares Number
26,289.0870
26,289.0870
25,775.5380
25,352.2570
12/31/2020 - 4/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRXBF NUREXONE BIOLOGIC INC
0.3960
-5.71%
OSE.PA OSE Immunotherapeutics SA
6.64
+0.15%
AKTX Akari Therapeutics, Plc
0.9201
+1.11%
SLGL Sol-Gel Technologies Ltd.
0.5550
+0.91%
SYRE Spyre Therapeutics, Inc.
19.00
-7.99%
UPB Upstream Bio, Inc.
7.66
-0.91%
BOLT Bolt Biotherapeutics, Inc.
0.4600
-3.10%
XNCR Xencor, Inc.
14.38
-0.48%
PRLD Prelude Therapeutics Incorporated
0.8084
+0.30%
APRE Aprea Therapeutics, Inc.
2.5500
-0.39%